{"id":6476,"date":"2018-11-25T09:01:00","date_gmt":"2018-11-25T09:01:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=6476"},"modified":"2024-05-02T11:15:18","modified_gmt":"2024-05-02T09:15:18","slug":"p442-the-additional-value-of-cytapheresis-therapy-in-patients-with-severe-ulcerative-colitis-treated-with-oral-tacrolimus","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/de\/professional\/scientific-corner\/p442-the-additional-value-of-cytapheresis-therapy-in-patients-with-severe-ulcerative-colitis-treated-with-oral-tacrolimus\/","title":{"rendered":"P442 The additional value of cytapheresis therapy in patients with severe ulcerative colitis treated with oral tacrolimus"},"content":{"rendered":"
\n

S Takahashi<\/a>,\u00a0M Colvin<\/a>,\u00a0J Toyosawa<\/a>,\u00a0M Ishida<\/a>,\u00a0T Kagawa<\/a>,\u00a0S Kuraoka<\/a>,\u00a0Y Aoyama<\/a>,\u00a0K Okamoto<\/a>,\u00a0I Sakakihara<\/a>,\u00a0K Izumikawa<\/a>,\u00a0K Yamamoto<\/a>,\u00a0S Tanaka<\/a>,\u00a0M Matsuura<\/a>,\u00a0S Ishikawa<\/a>,\u00a0M Wato<\/a>,\u00a0T Hasui<\/a>,\u00a0T Inaba<\/a>, Journal of Crohn’s and Colitis<\/em>, Volume 12, Issue supplement_1, February 2018<\/p>\n<\/div>\n\n

\n

Cytapheresis therapy as an additional therapy to oral tacrolimus is effective in patients with severe ulcerative colitis.<\/p>\n<\/div>\n\n

\n

)<\/a>https:\/\/academic.oup.com\/ecco-jcc\/article\/12\/supplement_1\/S328\/4808317<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

S Takahashi,\u00a0M Colvin,\u00a0J Toyosawa,\u00a0M Ishida,\u00a0T Kagawa,\u00a0S Kuraoka,\u00a0Y Aoyama,\u00a0K Okamoto,\u00a0I Sakakihara,\u00a0K Izumikawa,\u00a0K Yamamoto,\u00a0S Tanaka,\u00a0M Matsuura,\u00a0S Ishikawa,\u00a0M Wato,\u00a0T Hasui,\u00a0T Inaba, Journal of Crohn’s and Colitis, Volume 12, Issue supplement_1, February 2018 Cytapheresis therapy as an additional therapy to oral tacrolimus is effective in patients with severe ulcerative colitis. )https:\/\/academic.oup.com\/ecco-jcc\/article\/12\/supplement_1\/S328\/4808317<\/p>\n","protected":false},"template":"","scientific_tags":[380,352,376,306],"class_list":["post-6476","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-cytapheresis","scientific_tags-tacrolimus","scientific_tags-therapy","scientific_tags-ulcerative-colitis"],"acf":{"sc_authors":"https:\/\/academic.oup.com\/ecco-jcc\/article\/12\/supplement_1\/S328\/4808317<\/a>"},"yoast_head":"\nP442 The additional value of cytapheresis therapy in patients with severe ulcerative colitis treated with oral tacrolimus - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p442-the-additional-value-of-cytapheresis-therapy-in-patients-with-severe-ulcerative-colitis-treated-with-oral-tacrolimus\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"P442 The additional value of cytapheresis therapy in patients with severe ulcerative colitis treated with oral tacrolimus - Adacyte\" \/>\n<meta property=\"og:description\" content=\"S Takahashi,\u00a0M Colvin,\u00a0J Toyosawa,\u00a0M Ishida,\u00a0T Kagawa,\u00a0S Kuraoka,\u00a0Y Aoyama,\u00a0K Okamoto,\u00a0I Sakakihara,\u00a0K Izumikawa,\u00a0K Yamamoto,\u00a0S Tanaka,\u00a0M Matsuura,\u00a0S Ishikawa,\u00a0M Wato,\u00a0T Hasui,\u00a0T Inaba, Journal of Crohn’s and Colitis, Volume 12, Issue supplement_1, February 2018 Cytapheresis therapy as an additional therapy to oral tacrolimus is effective in patients with severe ulcerative colitis. )https:\/\/academic.oup.com\/ecco-jcc\/article\/12\/supplement_1\/S328\/4808317\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p442-the-additional-value-of-cytapheresis-therapy-in-patients-with-severe-ulcerative-colitis-treated-with-oral-tacrolimus\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-02T09:15:18+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p442-the-additional-value-of-cytapheresis-therapy-in-patients-with-severe-ulcerative-colitis-treated-with-oral-tacrolimus\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p442-the-additional-value-of-cytapheresis-therapy-in-patients-with-severe-ulcerative-colitis-treated-with-oral-tacrolimus\/\",\"name\":\"P442 The additional value of cytapheresis therapy in patients with severe ulcerative colitis treated with oral tacrolimus - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2018-11-25T09:01:00+00:00\",\"dateModified\":\"2024-05-02T09:15:18+00:00\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p442-the-additional-value-of-cytapheresis-therapy-in-patients-with-severe-ulcerative-colitis-treated-with-oral-tacrolimus\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"P442 The additional value of cytapheresis therapy in patients with severe ulcerative colitis treated with oral tacrolimus - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p442-the-additional-value-of-cytapheresis-therapy-in-patients-with-severe-ulcerative-colitis-treated-with-oral-tacrolimus\/","og_locale":"de_DE","og_type":"article","og_title":"P442 The additional value of cytapheresis therapy in patients with severe ulcerative colitis treated with oral tacrolimus - Adacyte","og_description":"S Takahashi,\u00a0M Colvin,\u00a0J Toyosawa,\u00a0M Ishida,\u00a0T Kagawa,\u00a0S Kuraoka,\u00a0Y Aoyama,\u00a0K Okamoto,\u00a0I Sakakihara,\u00a0K Izumikawa,\u00a0K Yamamoto,\u00a0S Tanaka,\u00a0M Matsuura,\u00a0S Ishikawa,\u00a0M Wato,\u00a0T Hasui,\u00a0T Inaba, Journal of Crohn’s and Colitis, Volume 12, Issue supplement_1, February 2018 Cytapheresis therapy as an additional therapy to oral tacrolimus is effective in patients with severe ulcerative colitis. )https:\/\/academic.oup.com\/ecco-jcc\/article\/12\/supplement_1\/S328\/4808317","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p442-the-additional-value-of-cytapheresis-therapy-in-patients-with-severe-ulcerative-colitis-treated-with-oral-tacrolimus\/","og_site_name":"Adacyte","article_modified_time":"2024-05-02T09:15:18+00:00","twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p442-the-additional-value-of-cytapheresis-therapy-in-patients-with-severe-ulcerative-colitis-treated-with-oral-tacrolimus\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p442-the-additional-value-of-cytapheresis-therapy-in-patients-with-severe-ulcerative-colitis-treated-with-oral-tacrolimus\/","name":"P442 The additional value of cytapheresis therapy in patients with severe ulcerative colitis treated with oral tacrolimus - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2018-11-25T09:01:00+00:00","dateModified":"2024-05-02T09:15:18+00:00","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/p442-the-additional-value-of-cytapheresis-therapy-in-patients-with-severe-ulcerative-colitis-treated-with-oral-tacrolimus\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner\/6476","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/media?parent=6476"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific_tags?post=6476"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}